Apoptotic Cells with Oxidation-specific Epitopes Are Immunogenic and Proinflammatory
Overview
General Medicine
Authors
Affiliations
Oxidation of low density lipoprotein (LDL) generates a variety of oxidatively modified lipids and lipid-protein adducts that are immunogenic and proinflammatory, which in turn contribute to atherogenesis. Cells undergoing apoptosis also display oxidized moieties on their surface membranes, as determined by binding of oxidation-specific monoclonal antibodies. In the present paper, we demonstrated by mass spectrometry that in comparison with viable cells, membranes of cells undergoing apoptosis contain increased levels of biologically active oxidized phospholipids (OxPLs). Indeed, immunization of mice with syngeneic apoptotic cells induced high autoantibody titers to various oxidation-specific epitopes of oxidized LDL, including OxPLs containing phosphorylcholine, whereas immunization with viable thymocytes, primary necrotic thymocytes, or phosphate-buffered saline did not. Reciprocally, these antisera specifically bound to apoptotic cells through the recognition of oxidation-specific epitopes. Moreover, splenocyte cultures from mice immunized with apoptotic cells spontaneously released significant levels of T helper cell (Th) 1 and Th2 cytokines, whereas splenocytes from controls yielded only low levels. Finally, we demonstrated that the OxPLs of apoptotic cells activated endothelial cells to induce monocyte adhesion, a proinflammatory response that was abrogated by an antibody specific to oxidized phosphatidylcholine. These results suggest that apoptotic cell death generates oxidatively modified moieties, which can induce autoimmune responses and a local inflammatory response by recruiting monocytes via monocyte-endothelial cell interaction.
The complement system in lipid-mediated pathologies.
Alic L, Dendinovic K, Papac-Milicevic N Front Immunol. 2024; 15:1511886.
PMID: 39635529 PMC: 11614835. DOI: 10.3389/fimmu.2024.1511886.
Ondracek A, Afonyushkin T, Aszlan A, Taqi S, Koller T, Artner T Eur Heart J. 2024; 46(10):926-939.
PMID: 39215577 PMC: 11887544. DOI: 10.1093/eurheartj/ehae584.
Atherosclerosis antigens as targets for immunotherapy.
Raposo-Gutierrez I, Rodriguez-Ronchel A, Ramiro A Nat Cardiovasc Res. 2024; 2(12):1129-1147.
PMID: 39196152 DOI: 10.1038/s44161-023-00376-x.
Tipping the Scale: Atheroprotective IgM-Producing B Cells in Atherosclerosis.
Ransegnola B, Pattarabanjird T, McNamara C Arterioscler Thromb Vasc Biol. 2024; 44(9):1906-1915.
PMID: 39022832 PMC: 11338718. DOI: 10.1161/ATVBAHA.124.319847.
Toshkova N, Zhelyzkova V, Reyes-Ruiz A, Haerens E, Deus M, Lacombe R Nat Commun. 2024; 15(1):5878.
PMID: 38997292 PMC: 11245544. DOI: 10.1038/s41467-024-50316-x.